XO Life: From German Startup to Pioneer Across Europe

Despite the initial euphoria during the pandemic, investments began to fall in 2022, and 2023 saw the lowest investments in digital health since 2018 in Europe, at just 1.4 billion dollars. The challenges facing the industry are enormous. In addition to regulatory hurdles, there is also the question of who bears the costs of online health services. While clear guidelines are emerging in some countries, such as Germany, digital health remains non-refundable in other countries.

In this difficult environment, XO Life, a former startup, stands out as a pioneer. XO Life has made a name for itself through its innovative use of patient-reported results (PROs) and its collaboration with major institutions such as Charité and the European Organization for Research and Treatment of Cancer (EORTC). The platform has not only shown that it can collect important patient data, but also that it can use this data to improve patient care.